The role of probiotics in improving menstrual health in women with primary dysmenorrhoea: A randomized, double-blind, placebo-controlled trial (the PERIOD study).

Journal: Women's health (London, England)

Volume: 20

Issue: 

Year of Publication: 2024

Affiliated Institutions:  Department of Obstetrics and Gynaecology, Faculty of Medicine, National University of Malaysia, Kuala Lumpur, Malaysia. Department of Community Health, Faculty of Medicine, National University of Malaysia, Kuala Lumpur, Malaysia. Department of Physiology, Faculty of Medicine, National University of Malaysia, Kuala Lumpur, Malaysia. Department of Medicine, Faculty of Medicine, National University of Malaysia, Kuala Lumpur, Malaysia.

Abstract summary 

Primary dysmenorrhea is associated with poorer quality of life; however, the causal mechanism remains unclear. A vast body of literature supports the use of oral probiotics for relief from the symptoms of endometriosis; however, to our knowledge, no study has prescribed probiotics for primary dysmenorrhea.The aim of this study is to investigate the effects of 3-month supplementation with oral probiotics on quality of life and inflammatory markers in women with primary dysmenorrhea.Randomized placebo-controlled trial.A total of 72 patients (36 patients in each arm) were randomized to receive either oral sachets containing 5 billion colony-forming units each of each or placebo twice daily for 3 months. Main outcome measures were visual analog scale, verbal rating scale, physical and mental health scores using Short-Form 12-Item version 2 questionnaire, frequency of nonsteroidal anti-inflammatory drug use, and changes in inflammatory markers (interleukin-6, interleukin-8, and tumor necrosis factor alpha) before and after treatment.There was no significant difference in the quality of life scores between the probiotic and placebo groups. Both groups showed significant improvement in pain (visual analog scale) and severity (verbal rating scale) scores but the probiotic group had much lower nonsteroidal anti-inflammatory drug use (odds ratio: 0.69, 95% confidence interval: 0.26-1.83) and better mental health scores (mean change: 6.5,  = 0.03 versus 6.1,  = 0.08) than the placebo group. There was a significant confounding effect of nonsteroidal anti-inflammatory drug use on quality of life scores. No significant difference was found in inflammatory cytokines.Tested oral probiotics improved mental health and potentially reduced the use of nonsteroidal anti-inflammatory drugs; however, there was no significant change in inflammatory markers. Further research with a larger sample size is needed to confirm the findings.This study is registered under ClinicalTrials.gov (NCT04119011).

Authors & Co-authors:  Zakaria Mohammed Zain Teik Abu Zainuddin Abdul Aziz Safian Mohd Mokhtar Raja Ali Beng Kwang Mohamed Ismail Hamizan Ab Razak Nur Azurah

Study Outcome 

Source Link: Visit source

Statistics
Citations :  Nur Azurah AG, Sanci L, Moore E, et al.. The quality of life of adolescents with menstrual problems. J Pediatr Adolesc Gynecol 2013; 26: 102–108.
Authors :  14
Identifiers
Doi : 17455057241234524
SSN : 1745-5065
Study Population
Women
Mesh Terms
Humans
Other Terms
inflammatory markers;menstrual disorders;primary dysmenorrheal;probiotics;quality of life
Study Design
Study Approach
Country of Study
Publication Country
United States